Skip to main content

Bridgeway Capital Management, Llc

Source: SEC Form 13F · as of Mar 2026

Bridgeway Capital Management, Llc holds 65 biotech & pharma companies tracked by BioSniper, totaling $37.2M in value as of Mar 2026 (SEC Form 13F).

Companies held

65

Total value held

$37.2M

BioSniper AIPage evidence connected

Prepared research question

What matters most for PUMA BIOTECHNOLOGY, INC. (PBYI)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
PBYIPUMA BIOTECHNOLOGY, INC.775,341$5.0M
EXELEXELIXIS, INC.66,100$2.8M
SUPNSUPERNUS PHARMACEUTICALS, INC.48,000$2.5M
KROSKeros Therapeutics, Inc.195,017$2.2M
SGMTSagimet Biosciences Inc.299,641$1.6M
BDTXBlack Diamond Therapeutics, Inc.723,477$1.5M
PTCTPTC THERAPEUTICS, INC.22,000$1.5M
BIOABioAge Labs, Inc.57,600$1.0M
CLYMClimb Bio, Inc.134,300$920K
CHRSCoherus Oncology, Inc.441,000$745K
WHWKWhitehawk Therapeutics, Inc.215,284$743K
IMMXImmix Biopharma, Inc.80,000$729K
TENXTENAX THERAPEUTICS, INC.44,900$718K
PLRXPLIANT THERAPEUTICS, INC.553,630$698K
KODKodiak Sciences Inc.18,200$694K
TERNTerns Pharmaceuticals, Inc.12,000$633K
INVAInnoviva, Inc.24,188$564K
DSGNDesign Therapeutics, Inc.52,000$553K
XOMAXOMA Royalty Corporation17,580$551K
ANNXAnnexon, Inc.97,800$542K
MGXMetagenomi Therapeutics, Inc.395,800$530K
FENCFENNEC PHARMACEUTICALS INC.83,005$510K
ZURAZura Bio Ltd85,348$508K
FDMT4D Molecular Therapeutics, Inc.50,000$466K
CATXPerspective Therapeutics, Inc.110,800$462K
ARMPArmata Pharmaceuticals, Inc.44,682$458K
PLXProtalix BioTherapeutics, Inc.189,100$410K
NGNENeurogene Inc.18,781$379K
OLMAOlema Pharmaceuticals, Inc.25,000$373K
CADLCandel Therapeutics, Inc.75,100$368K
LYELLyell Immunopharma, Inc.18,000$361K
LCTXLineage Cell Therapeutics, Inc.221,000$349K
CCCCC4 Therapeutics, Inc.131,100$345K
VYGRVoyager Therapeutics, Inc.87,459$338K
TRDAEntrada Therapeutics, Inc.25,000$316K
ALECAlector, Inc.142,500$306K
ASRTAssertio Holdings, Inc.16,014$305K
INOINOVIO PHARMACEUTICALS, INC.173,000$301K
TNGXTango Therapeutics, Inc.14,000$293K
SPROSpero Therapeutics, Inc.114,800$269K
ARTVArtiva Biotherapeutics, Inc.35,000$225K
ABEOABEONA THERAPEUTICS INC.50,000$224K
FATEFATE THERAPEUTICS INC185,000$222K
OVIDOvid Therapeutics Inc.95,434$212K
ANTXAN2 Therapeutics, Inc.59,900$205K
IRDOpus Genetics, Inc.42,065$191K
LRMRLarimar Therapeutics, Inc.41,216$185K
PRLDPrelude Therapeutics Inc53,500$183K
ZNTLZentalis Pharmaceuticals, Inc.77,300$181K
SLDBSolid Biosciences Inc.23,460$169K
RNACCartesian Therapeutics, Inc.25,000$154K
ALXOALX ONCOLOGY HOLDINGS INC76,072$153K
KLRSKalaris Therapeutics, Inc.22,500$130K
BMEABiomea Fusion, Inc.84,600$129K
IVVDInvivyd, Inc.99,200$129K
HUMAHumacyte Inc.210,000$127K
CAMPCamp4 Therapeutics Corp25,000$110K
AARDAardvark Therapeutics, Inc.27,000$102K
ANVSAnnovis Bio, Inc.37,677$84K
MNOVMEDICINOVA INC56,031$77K
OKUROnKure Therapeutics, Inc.16,293$67K
HOWLWerewolf Therapeutics, Inc.77,000$64K
HYFTMindWalk Holdings Corp.50,000$57K
ATNMActinium Pharmaceuticals, Inc.40,000$40K
NNVCNANOVIRICIDES, INC.36,039$33K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.